Moreover, in a study involving calcitriol treatment of secondary hyperparathyroidism in CKD patients, it was demonstrated that the increased secretion of osteoclast-derived Wnt10b was critical for the improvement of bone anabolism through its inhibition of osteoclastogenesis and promotion osteoblastogenesis (23). Here, WNT10B is linked to chronic kidney disease.